J. David Joyner Cvs Health Corp (CVS) insider trading activity

J. David Joyner is President and CEO of CVS HEALTH Corp. Currently has a direct ownership of 44,241 shares of CVS, which is worth approximately $1.94 Million. The most recent transaction as insider was on Apr 01, 2024, when has been sold 28,280 shares (Common Stock (restricted)) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.2K

0% 3M change

84.8% 12M change

Total Value Held $1.94 Million

J. David Joyner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	BUY Grant, award, or other acquisition	-	28,280 Added 39.0%	44,241 Common Stock (restricted)
Feb 28 2024	SELL Payment of exercise price or tax liability	$148,124 $75.19 p/Share	1,970 Reduced 4.62%	40,681 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	$1,999,947 $83.54 p/Share	23,940 Added 50.0%	23,940 Common Stock (restricted)
Apr 03 2017	BUY Grant, award, or other acquisition	$349,976 $78.05 p/Share	4,484 Added 21.87%	16,015 Common Stock (restricted)
Apr 02 2017	SELL Payment of exercise price or tax liability	$146,167 $78.5 p/Share	1,862 Reduced 2.5%	72,601 Common Stock
Apr 01 2017	SELL Payment of exercise price or tax liability	$66,490 $78.5 p/Share	847 Reduced 1.12%	74,463 Common Stock
Feb 28 2017	SELL Payment of exercise price or tax liability	$137,389 $80.58 p/Share	1,705 Reduced 2.42%	68,853 Common Stock
Feb 28 2017	BUY Grant, award, or other acquisition	$499,999 $80.58 p/Share	6,205 Added 8.08%	70,558 Common Stock
Apr 01 2016	SELL Payment of exercise price or tax liability	$121,067 $104.82 p/Share	1,155 Reduced 1.76%	64,353 Common Stock
Apr 01 2016	BUY Grant, award, or other acquisition	$349,994 $104.82 p/Share	3,339 Added 15.66%	17,988 Common Stock (restricted)
Feb 29 2016	BUY Grant, award, or other acquisition	$542,403 $97.17 p/Share	5,582 Added 8.17%	62,757 Common Stock
Apr 02 2015	SELL Payment of exercise price or tax liability	$191,246 $102.71 p/Share	1,862 Reduced 3.15%	57,175 Common Stock
Apr 01 2015	SELL Payment of exercise price or tax liability	$184,170 $102.26 p/Share	1,801 Reduced 3.19%	54,599 Common Stock
Apr 01 2015	BUY Grant, award, or other acquisition	$349,934 $102.26 p/Share	3,422 Added 16.43%	17,400 Common Stock (restricted)
Feb 27 2015	BUY Grant, award, or other acquisition	$624,986 $103.87 p/Share	6,017 Added 10.35%	52,109 Common Stock
Feb 07 2015	SELL Payment of exercise price or tax liability	$26,460 $100.61 p/Share	263 Reduced 0.57%	46,092 Common Stock
Aug 06 2014	SELL Open market or private sale	$9,399,567 $76.1 p/Share	123,516 Reduced 73.12%	45,399 Common Stock
Aug 06 2014	BUY Exercise of conversion of derivative security	$3,973,509 $32.17 p/Share	123,516 Added 57.5%	91,296 Common Stock
Apr 01 2014	SELL Payment of exercise price or tax liability	$683,691 $74.29 p/Share	9,203 Reduced 16.85%	45,399 Common Stock
Apr 01 2014	BUY Grant, award, or other acquisition	$299,983 $74.29 p/Share	4,038 Added 14.58%	23,663 Common Stock (restricted)

JDJ

J. David Joyner

President and CEO

Woonsocket, RI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Value

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS

Account